Results for:(80 found)
Aug 28, 2012 2:45PM on Top StocksBy Minyanville.com

The US approval of Stribild is a big plus for the company's AIDS treatment franchise.

Aug 2, 2012 3:56PM on Top StocksBy Jim J. Jubak

Shares of a 3% dividend yield, solid blue-chip drug company are valuable in shaky economic times.

Jul 18, 2012 11:28AM on Top StocksBy Minyanville.com

Vivus becomes the second pharma this year approved to sell a weight-loss treatment.

Jul 18, 2012 8:41AM on Top StocksBy MSN Money Partner

The banking giant reports a profit, and the semiconductor company reports earnings above expectations.

Jun 20, 2012 3:31PM on Top StocksBy Minyanville

Investors hope the company has a next-generation treatment for the virus. The new data will fuel more takeover talk.

Jun 18, 2012 10:14AM on Top StocksBy TheStockAdvisors

These shares offer regular dividends, a key to steady income. And most are rated as low risk.

May 10, 2012 12:07PM on Top StocksBy MoneyShow.com

A jittery Europe, a slowing China, and a weak US recovery means rock-solid income is a great choice for investors looking to ride out the storm.

Apr 18, 2012 3:07PM on Top StocksBy Jim J. Jubak

The stock deserves a higher price than the market seems willing to give.

Tags: ABT

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.